IBM Retirement Fund’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,424
Closed -$216K 549
2021
Q4
$216K Sell
5,424
-3,760
-41% -$146K 0.03% 521
2021
Q3
$332K Hold
9,184
0.03% 538
2021
Q2
$376K Sell
9,184
-1,772
-16% -$75.4K 0.03% 511
2021
Q1
$478K Buy
+10,956
New +$519K 0.03% 464

Other funds holding RPRX

IBM Retirement Fund's RPRX Position: Q1 2022 in Review

IBM Retirement Fund sold out of Royalty Pharma (RPRX) in Q1 2022, closing a stake of 5,424 shares — an estimated $216K sold.

IBM Retirement Fund first reported a position in RPRX in Q1 2021 and held it in 4 quarters. The position peaked at $478K in Q1 2021. 279 funds tracked by Wall St. Rank hold RPRX as of Q1 2022.

  • IBM Retirement Fund reported no remaining Royalty Pharma position as of Q1 2022 after selling out during the quarter.
  • IBM Retirement Fund sold 5,424 Royalty Pharma shares in Q1 2022, an estimated $216K.
  • IBM Retirement Fund first reported a position in Royalty Pharma in Q1 2021 and held it in 4 quarters.
  • IBM Retirement Fund's Royalty Pharma position peaked at $478K in Q1 2021.
  • 279 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2022.

Based on IBM Retirement Fund's 13F filing for Q1 2022, filed 14 Apr 2022.